UPDATE: Lilly's next obesity drug just cut an average of 58 pounds—prompting an all-out phase 3 blitz - FierceBiotech fiercebiotech.com Submitted by fiercebiotech9600 on June 27, 2023 at 12:45 AM in business No comments 38